Authors: Hakan, Tayfun¹; Toklu, Hale²; Biber, Necat¹; Ozevren, Huseyin¹; Solakoglu, Seyhun³; Demirturk, Pelin⁴; Aker, Fugen⁴

Source: Neurological Research, Volume 32, Number 6, July 2010 , pp. 629-635(7)

Publisher: Maney Publishing

Abstract:

Objective: The overproduction of reactive oxygen species and resultant damage to cellular proteins or lipids of cell membranes and DNA by free radicals are the underlying mechanisms of many neuropathologies. Cyclooxygenase-2 (COX-2) inhibitors have been suggested to be neuroprotective by reducing prostanoid and free radical synthesis, or by directing arachidonic acid metabolism through alternate pathways. This study investigated the putative neuroprotective effect of the COX-2 inhibitor, meloxicam, in a rat model of diffuse brain injury.

Methods: Sprague–Dawley rats were subjected to traumatic brain injury with a weight-drop device using 300 g⁻¹ m weight–height impact. The groups were: control, meloxicam (2 mg/kg, i.p.), trauma and trauma + meloxicam (2 mg/kg, i.p.). Forty-eight hours after the injury, neurological examination scores were measured, the animals were decapitated and brain tissues were taken. Brain edema and blood–brain barrier (BBB) permeability were evaluated by wet–dry weight method and Evans blue (EB) extravasation respectively. In brain tissues, malonedialdehyde, glutathione, myeloperoxidase and Na/K-ATPase levels were measured.

Results: The neurological examination scores mildly increased in trauma groups 48 hours after the induction of trauma. Meloxicam treatment improved the altered neurological status. The trauma caused a significant increase in brain water content that was partially reversed by meloxicam. Meloxicam also reduced the EB extravasation indicating the preservation of the BBB integrity. Meloxicam treatment also significantly reduced the increase in malondialdehyde and myeloperoxidase levels and restored glutathione content of the brains that had been significantly increased after trauma.

Conclusion: Meloxicam exerts neuroprotective effect by preserving BBB permeability and by reducing brain edema (probably by its anti-inflammatory properties) in the diffuse brain injury model.

Keywords: MELOXICAM; EDEMA; ANTIOXIDANT; BRAIN INJURY; BLOOD-BRAIN BARRIER; CLOSED HEAD TRAUMA

Document Type: Research Article

DOI: http://dx.doi.org/10.1179/016164109X12464612122731

Affiliations: 1: Department of Neurosurgery, Haydarpasa Numune Teaching and Research Hospital, Istanbul, Turkey 2: Department of Pharmacology, School of Pharmacy, Marmara University, Istanbul, Turkey 3: Department of Histology and Embryology, Istanbul School of Medicine, Istanbul University, Istanbul, Turkey 4: Department of Pathology, Haydarpasa Numune Teaching and Research Hospital, Istanbul, Turkey

Publication date: 2010-07-01

More about this publication?

• Authors wishing to cite fast track papers should give the journal name and the article DOI. This will enable reference linking via CrossRef and allow forward and backward citation tracking systems to associate the fast track citation with the final journal reference.

• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Virtual Maney - Stroke
• Top articles
• Health Sciences Spotlight
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Neurology & Psychiatry
• By this author: Hakan, Tayfun ;  Toklu, Hale ;  Biber, Necat ;  Ozevren, Huseyin ;  Solakoglu, Seyhun ;  Demirturk, Pelin ;  Aker, Fugen

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers